• Cost-effective subscriptions
• Customizable content
• Language options
• Tracking tools
Sign up through your affiliated organization or as an independent learner today.
LEARN MORE
Protocol Builder® makes the protocol writing, review, and approval process more efficient. Free 30-Day Trial is available for CITI Customers.
Updated NIH IND/IDE Template now available!
On 24 July 2017, the U.S. FDA issued guidance that it will not object if an IRB approves a waiver or alteration of consent for a no more than minimal risk clinical investigation.
Learn More
We invite you to review our April 2017 newsletter, which discusses recently added/updated content, features of our new public website, navigating sIRB review, FCOI management and training, and updates to our transactional emails.
Learn More
6-9 August 2017 in Washington D.C. - National Council of University Research (NCURA) Annual Conference
Learn More